Skip to main content
Erschienen in: Journal of Neurology 12/2014

01.12.2014 | Original Communication

Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)

verfasst von: Benjamin Bender, Uwe Klose, Tobias Lindig, Saskia Biskup, Thomas Nägele, Ludger Schöls, Kathrin N. Karle

Erschienen in: Journal of Neurology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal dominant disease caused by mutations within the colony stimulating factor 1 receptor (CSF1R) gene. While a small number of reports on imaging findings in routine MRI exist, reported imaging findings in DWI and spectroscopy are scarce, and limited to not genetically proven case reports. We assessed MRI including DWI and MR spectroscopy in six patients with HDLS and two asymptomatic mutation carriers. A total of 13 MRIs were evaluated and a score of the white-matter lesion (WML) load was calculated. The course of MR abnormalities was followed for 6–19 months in four patients and 95 months in one carrier. MRI revealed widespread white-matter lesions of patchy or confluent pattern especially in the frontal and occipital lobe. The pyramidal tract was less affected than the surrounding tissue in all symptomatic patients on conventional T2WI. Three of four cases with DWI showed small dots of diffusion restriction within WML. Spectroscopy showed increased levels of mIns, Cho and lactate while NAA was decreased. Asymptomatic mutation carriers had, for the age of the patients, unusually pronounced unspecific WMLs. No diffusion restriction or alterations in metabolite levels could be detected in asymptomatic mutation carriers. Microbleeds were not found in any patient. Diffusion restriction seems to be a typical imaging pattern visible in patients with active disease progression in HDLS. Spectroscopic findings and the absence of microbleeds differ clearly from reported findings in CADASIL and subcortical arteriosclerotic encephalopathy. While the distribution and character of WMLs in asymptomatic cases remain unspecific they are likely to represent subclinical markers of HDLS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Axelsson R, Röyttä M, Sourander P, Akesson HO, Andersen O (1984) Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 314:1–65PubMed Axelsson R, Röyttä M, Sourander P, Akesson HO, Andersen O (1984) Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 314:1–65PubMed
2.
Zurück zum Zitat Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Jam Van Gerpen et al (2011) Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 44:200–205PubMedCentralCrossRefPubMed Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Jam Van Gerpen et al (2011) Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 44:200–205PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wzzolek ZK (2009) Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology 72:1953–1959PubMedCentralCrossRefPubMed Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wzzolek ZK (2009) Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology 72:1953–1959PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R (2013) CSF1R mutations link POLD and HDLS as a single disease entity. Neurology 80:1033–1040PubMedCentralCrossRefPubMed Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, Nelson PT, Clark HB, Wszolek ZK, Dickson DW, Knopman DS, Rademakers R (2013) CSF1R mutations link POLD and HDLS as a single disease entity. Neurology 80:1033–1040PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK (2012) MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 79:566–574PubMedCentralCrossRefPubMed Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, Broderick D, Wszolek ZK (2012) MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 79:566–574PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA (2008) Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology 70:1128–1133CrossRefPubMed Keegan BM, Giannini C, Parisi JE, Lucchinetti CF, Boeve BF, Josephs KA (2008) Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology 70:1128–1133CrossRefPubMed
7.
Zurück zum Zitat Itoh K, Shiga K, Shimizu K, Muranishi M, Nakagawa M, Fushiki S (2006) Autosomal dominant leukodystrophy with axonal spheroids and pigmented glia: clinical and neuropathological characteristics. Acta Neuropathol 111:39–45CrossRefPubMed Itoh K, Shiga K, Shimizu K, Muranishi M, Nakagawa M, Fushiki S (2006) Autosomal dominant leukodystrophy with axonal spheroids and pigmented glia: clinical and neuropathological characteristics. Acta Neuropathol 111:39–45CrossRefPubMed
8.
Zurück zum Zitat Kinoshita M, Yoshida K, Oyanagi K, Hashimoto T, Ikeda S (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids caused by R782H mutation in CSF1R: case report. J Neurol Sci 318:115–118CrossRefPubMed Kinoshita M, Yoshida K, Oyanagi K, Hashimoto T, Ikeda S (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids caused by R782H mutation in CSF1R: case report. J Neurol Sci 318:115–118CrossRefPubMed
9.
Zurück zum Zitat Kondo Y, Kinoshita M, Fukushima K, Yoshida K, Ikeda S (2013) Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R. Intern Med 52:503–506CrossRefPubMed Kondo Y, Kinoshita M, Fukushima K, Yoshida K, Ikeda S (2013) Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R. Intern Med 52:503–506CrossRefPubMed
10.
Zurück zum Zitat Karle KN, Biskup S, Schüle R, Schweitzer KJ, Krüger R, Bauer P, Bender B, Nägele T, Schöls L (2013) De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology 81:2039–2044CrossRefPubMed Karle KN, Biskup S, Schüle R, Schweitzer KJ, Krüger R, Bauer P, Bender B, Nägele T, Schöls L (2013) De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology 81:2039–2044CrossRefPubMed
11.
Zurück zum Zitat Hoffmann S, Murrell J, Harms L, Miller K, Meisel A, Brosch T, Scheel M, Ghetti B, Goebel HH, Stenzel W (2014) Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol. doi:10.1111/bpa.12120 (in press) Hoffmann S, Murrell J, Harms L, Miller K, Meisel A, Brosch T, Scheel M, Ghetti B, Goebel HH, Stenzel W (2014) Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol. doi:10.​1111/​bpa.​12120 (in press)
12.
Zurück zum Zitat Konno T, Tada M, Tada M, Koyama A, Nozaki H, Harigaya Y, Nishimiya J, Matsunaga A, Yoshikura N, Ishihara K, Arakawa M, Isami A, Okazaki K, Yokoo H, Itoh K, Yoneda M, Kawamura M, Inuzuka T, Takahashi H, Nishizawa M, Onodera O, Kakita A, Ikeuchi T (2014) Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. Neurology 82:139–148PubMedCentralCrossRefPubMed Konno T, Tada M, Tada M, Koyama A, Nozaki H, Harigaya Y, Nishimiya J, Matsunaga A, Yoshikura N, Ishihara K, Arakawa M, Isami A, Okazaki K, Yokoo H, Itoh K, Yoneda M, Kawamura M, Inuzuka T, Takahashi H, Nishizawa M, Onodera O, Kakita A, Ikeuchi T (2014) Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS. Neurology 82:139–148PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Terasawa Y, Osaki Y, Kawarai T, Sugimoto T, Orlacchio A, Abe T, Izumi Y, Kaji R (2013) Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids. J Neurol Sci 335:213–214CrossRefPubMed Terasawa Y, Osaki Y, Kawarai T, Sugimoto T, Orlacchio A, Abe T, Izumi Y, Kaji R (2013) Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids. J Neurol Sci 335:213–214CrossRefPubMed
14.
Zurück zum Zitat Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ (2010) Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry 81:619–622CrossRefPubMed Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ (2010) Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry 81:619–622CrossRefPubMed
15.
Zurück zum Zitat Boissé L, Islam O, Woulfe J, Ludwin SK, Brunet DG (2010) Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings. J Neurol Neurosurg Psychiatry 81:313–340CrossRefPubMed Boissé L, Islam O, Woulfe J, Ludwin SK, Brunet DG (2010) Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings. J Neurol Neurosurg Psychiatry 81:313–340CrossRefPubMed
16.
Zurück zum Zitat Sundal C, Ekholm S, Nordborg C, Jönsson L, Börjesson-Hanson A, Lindén T, Zetterberg H, Viitanen M, Andersen O (2012) Update of the original HDLS kindred: divergent clinical causes. Acta Neurol Scand 126:67–75CrossRefPubMed Sundal C, Ekholm S, Nordborg C, Jönsson L, Börjesson-Hanson A, Lindén T, Zetterberg H, Viitanen M, Andersen O (2012) Update of the original HDLS kindred: divergent clinical causes. Acta Neurol Scand 126:67–75CrossRefPubMed
17.
Zurück zum Zitat Freeman SH, Hyman BT, Sims KB, Hedley-Whyte ET, Vossough A, Frosch MP, Schmahmann JD (2009) Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol 19:39–47PubMedCentralCrossRefPubMed Freeman SH, Hyman BT, Sims KB, Hedley-Whyte ET, Vossough A, Frosch MP, Schmahmann JD (2009) Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol 19:39–47PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Sundal C, Lash J, Aasly J, Øygarden S, Roeber S, Kretzschman H, Garbern JY, Tselis A, Rademakers R, Dickson DW, Broderick D, Wszolek ZK (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease ententity. J Neurol Sci 314:130–137PubMedCentralCrossRefPubMed Sundal C, Lash J, Aasly J, Øygarden S, Roeber S, Kretzschman H, Garbern JY, Tselis A, Rademakers R, Dickson DW, Broderick D, Wszolek ZK (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease ententity. J Neurol Sci 314:130–137PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Sohn SY, Ko YJ, Hong JM, Kim SH, Kim HS, Kim JH, Chi JG, Moon SY (2010) A case of pigmentary orthochromatic leukodystrophy with findings of proton MR spectroscopy and serial brain MRIs. J Neurol Sci 295:23–26CrossRefPubMed Sohn SY, Ko YJ, Hong JM, Kim SH, Kim HS, Kim JH, Chi JG, Moon SY (2010) A case of pigmentary orthochromatic leukodystrophy with findings of proton MR spectroscopy and serial brain MRIs. J Neurol Sci 295:23–26CrossRefPubMed
20.
Zurück zum Zitat Terada S, Ishizu H, Yokota O, Ishihara T, Nakashima H, Kugo A, Tanaka Y, Nakashima T, Nakashima Y, Kuroda S (2004) An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer’s disease. Acta Neuropathol 108:538–545CrossRefPubMed Terada S, Ishizu H, Yokota O, Ishihara T, Nakashima H, Kugo A, Tanaka Y, Nakashima T, Nakashima Y, Kuroda S (2004) An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer’s disease. Acta Neuropathol 108:538–545CrossRefPubMed
21.
Zurück zum Zitat Mendes A, Pinto M, Vieira S, Castro L, Carpenter S (2010) Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci 297:40–45CrossRefPubMed Mendes A, Pinto M, Vieira S, Castro L, Carpenter S (2010) Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci 297:40–45CrossRefPubMed
22.
Zurück zum Zitat Baba Y, Ghetti B, Baker MC, Uitti RJ, Hutton ML, Yamaguchi K, Bird T, Lin W, DeLucia MW, Dickson DW, Wszolek ZK (2006) Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 111:300–311CrossRefPubMed Baba Y, Ghetti B, Baker MC, Uitti RJ, Hutton ML, Yamaguchi K, Bird T, Lin W, DeLucia MW, Dickson DW, Wszolek ZK (2006) Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 111:300–311CrossRefPubMed
23.
Zurück zum Zitat Yamashita M, Yamamoto T (2002) Neuroaxonal leukencephalopathy with axonal spheroids. Eur Neurol 48:20–25CrossRefPubMed Yamashita M, Yamamoto T (2002) Neuroaxonal leukencephalopathy with axonal spheroids. Eur Neurol 48:20–25CrossRefPubMed
24.
Zurück zum Zitat Browne L, Sweeney BJ, Farrell MA (2003) Late-onset neuroaxonal leukoencephalopathy with spheroids and vascular amyloid. Eur Neurol 50:85–90CrossRefPubMed Browne L, Sweeney BJ, Farrell MA (2003) Late-onset neuroaxonal leukoencephalopathy with spheroids and vascular amyloid. Eur Neurol 50:85–90CrossRefPubMed
25.
Zurück zum Zitat Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK (2008) Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 71:925–929PubMedCentralCrossRefPubMed Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK (2008) Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 71:925–929PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Sundal C, Ekholm S, Andersen O (2010) White matter disorders with autosomal dominant heredity: a review with personal clinical case studies and there MRI findings. Acta Neurol Scand 121:328–337CrossRefPubMed Sundal C, Ekholm S, Andersen O (2010) White matter disorders with autosomal dominant heredity: a review with personal clinical case studies and there MRI findings. Acta Neurol Scand 121:328–337CrossRefPubMed
27.
Zurück zum Zitat Mayer B, Oelschlaeger C, Keyvani K, Niederstadt T (2007) Two cases of LENAS: diagnosis by MRI and biopsy. J Neurol 254:1453–1454CrossRefPubMed Mayer B, Oelschlaeger C, Keyvani K, Niederstadt T (2007) Two cases of LENAS: diagnosis by MRI and biopsy. J Neurol 254:1453–1454CrossRefPubMed
28.
Zurück zum Zitat Maillart E, Rousseau A, Galanaud D, Gray F, Polivka M, Labauge P, Hauw JJ, Lyon-Caen O, Gout O, Sedel F (2009) Rapid onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids. J Neurol 256:1649–1654CrossRefPubMed Maillart E, Rousseau A, Galanaud D, Gray F, Polivka M, Labauge P, Hauw JJ, Lyon-Caen O, Gout O, Sedel F (2009) Rapid onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids. J Neurol 256:1649–1654CrossRefPubMed
29.
Zurück zum Zitat Moro-de-Casillas ML, Cohen ML, Riley DE (2004) Leukoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy. J Neurol Neurosurg Psychiatry 75:1070–1072PubMedCentralCrossRefPubMed Moro-de-Casillas ML, Cohen ML, Riley DE (2004) Leukoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy. J Neurol Neurosurg Psychiatry 75:1070–1072PubMedCentralCrossRefPubMed
30.
31.
Zurück zum Zitat van der Knaap MS, Naidu S, Kleinschmidt-Demasters BK, Kamphorst W, Weinstein HC (2000) Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 54:463–479CrossRefPubMed van der Knaap MS, Naidu S, Kleinschmidt-Demasters BK, Kamphorst W, Weinstein HC (2000) Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 54:463–479CrossRefPubMed
32.
Zurück zum Zitat Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004:169–179CrossRefPubMed Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004:169–179CrossRefPubMed
33.
Zurück zum Zitat Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R (1997) In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 68:161–172CrossRefPubMed Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R (1997) In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 68:161–172CrossRefPubMed
34.
Zurück zum Zitat Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54–84CrossRefPubMed Ross B, Bluml S (2001) Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54–84CrossRefPubMed
35.
Zurück zum Zitat López-Villegas D, Lenkinski RE, Wehrli SL, Douglas SD (1995) Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 34:32–38CrossRefPubMed López-Villegas D, Lenkinski RE, Wehrli SL, Douglas SD (1995) Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 34:32–38CrossRefPubMed
36.
Zurück zum Zitat Bender B, Bornemann A, Reimold M, Ernemann U, Horger M (2012) Imaging findings in autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)—CADASIL—the most frequent familial stroke syndrome. Rofo 184:679–683CrossRefPubMed Bender B, Bornemann A, Reimold M, Ernemann U, Horger M (2012) Imaging findings in autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)—CADASIL—the most frequent familial stroke syndrome. Rofo 184:679–683CrossRefPubMed
37.
Zurück zum Zitat Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) Cadasil. Lancet Neurol 8:643–653CrossRefPubMed Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) Cadasil. Lancet Neurol 8:643–653CrossRefPubMed
38.
Zurück zum Zitat Akhvlediani T, Henning A, Sándor PS, Boesiger P, Jung HH (2010) Adaptive metabolic changes in CADASIL white matter. J Neurol 257:171–177CrossRefPubMed Akhvlediani T, Henning A, Sándor PS, Boesiger P, Jung HH (2010) Adaptive metabolic changes in CADASIL white matter. J Neurol 257:171–177CrossRefPubMed
39.
Zurück zum Zitat Yao M, Jouvent E, Durin M, Godin O, Hervé D, Guichard JP, Zhu YC, Gschwendtner A, Opherk C, Dichgans M, Chabriat H (2012) Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarct and leukoencephalopathy. Stroke 43:3252–3257CrossRefPubMed Yao M, Jouvent E, Durin M, Godin O, Hervé D, Guichard JP, Zhu YC, Gschwendtner A, Opherk C, Dichgans M, Chabriat H (2012) Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarct and leukoencephalopathy. Stroke 43:3252–3257CrossRefPubMed
40.
Zurück zum Zitat Kinoshita M, Kondo Y, Yoshida K, Fukushima K, Hoshi K, Ishizawa K, Araki N, Yazawa I, Washimi Y, Saitoh B, Kira J, Ikeda S (2014) Corpus callosum atrophy in patients with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: an MRI-based study. Intern Med 53:21–27CrossRefPubMed Kinoshita M, Kondo Y, Yoshida K, Fukushima K, Hoshi K, Ishizawa K, Araki N, Yazawa I, Washimi Y, Saitoh B, Kira J, Ikeda S (2014) Corpus callosum atrophy in patients with hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: an MRI-based study. Intern Med 53:21–27CrossRefPubMed
41.
Zurück zum Zitat Kantarci K, Petersen C, Boeve BF, Knopman DS, Tang-Wai DF, O’Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopy in common dementias. Neurology 63:1393–1398PubMedCentralCrossRefPubMed Kantarci K, Petersen C, Boeve BF, Knopman DS, Tang-Wai DF, O’Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopy in common dementias. Neurology 63:1393–1398PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Nitkunan A, Charlton RA, Barrick TR, McIntyre DJO, Howe FA, Markus HS (2009) Reduced N-aceylaspartate is consistent with axonal dysfunction in cerebral small vessel disease. NMR Biomed 22:285–291CrossRefPubMed Nitkunan A, Charlton RA, Barrick TR, McIntyre DJO, Howe FA, Markus HS (2009) Reduced N-aceylaspartate is consistent with axonal dysfunction in cerebral small vessel disease. NMR Biomed 22:285–291CrossRefPubMed
43.
Zurück zum Zitat Seo SW, Lee BH, Kim E-J, Chin J, Sun Cho Y, Yoon U, Na DL (2007) Clinical significance of microbleeds in subcortical vascular dementia. Stroke 38:1949–1951CrossRefPubMed Seo SW, Lee BH, Kim E-J, Chin J, Sun Cho Y, Yoon U, Na DL (2007) Clinical significance of microbleeds in subcortical vascular dementia. Stroke 38:1949–1951CrossRefPubMed
44.
Zurück zum Zitat Balashov KE, Aung LL, Dhib-Jalbut S, Keller IA (2011) Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema. J Neuroimaging 21:202–204PubMedCentralCrossRefPubMed Balashov KE, Aung LL, Dhib-Jalbut S, Keller IA (2011) Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema. J Neuroimaging 21:202–204PubMedCentralCrossRefPubMed
45.
Zurück zum Zitat Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O (1994) Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 35:117–122CrossRefPubMed Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O (1994) Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 35:117–122CrossRefPubMed
Metadaten
Titel
Imaging features in conventional MRI, spectroscopy and diffusion weighted images of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)
verfasst von
Benjamin Bender
Uwe Klose
Tobias Lindig
Saskia Biskup
Thomas Nägele
Ludger Schöls
Kathrin N. Karle
Publikationsdatum
01.12.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7509-2

Weitere Artikel der Ausgabe 12/2014

Journal of Neurology 12/2014 Zur Ausgabe

Pioneers in Neurology

Walther Riese (1890–1976)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.